Cliniceval Solutions, LLC announces addition of Ira Davis, MD, MS as Chief Medical Advisor

(Cincinnati, OH, USA – August 6, 2018) – Cliniceval Solutions, LLC is pleased to announce the addition of Ira Davis, MD, MS as Chief Medical Advisor.

Dr. Davis is an accomplished physician with 20 years of academic experience in a general pediatrics and nephrology setting and more than 11 years of industry experience, with a focus on pharmaceutical, biotechnology and medical devices. Dr. Davis has served in a leadership capacity throughout his career, including roles as Division Chief of Pediatric Nephrology and Medical Director of the Pediatric Peritoneal Dialysis Center and Pediatric Renal Transplantation Program at Case Western Reserve University’s Rainbow Babies and Children’s Hospital from 1992-2007. He has held positions as Global Medical Director for Baxter International, Inc. and Hospira, providing oversight of the clinical and medical expert team of nurses and physicians supporting Research and Development activities for multiple dialysis products and infusion pumps,and as Medical Director at CTI Clinical Trial and Consulting Services, serving as a clinical and medical expert for biopharmaceutical and medical device companies regarding clinical development plans, protocol design and providing medical oversight of Phase I-III clinical trials. Dr. Davis has been involved in clinical trials for 30 years and has provided medical expertise in the start-up and execution of clinical trials in the areas of hypertension, anemia, chronic kidney disease, peritoneal dialysis, hemodialysis vascular access, solid organ transplantation, oncology, blood collection medical devices, and orphan drug development in the area of inherited metabolic diseases and chronic glomerular diseases.

“We are very privileged to have Dr. Davis join our team,” said Jim Westerkamp, President. “Ira adds a highly developed and unique set of skills to our team, all of which are an ideal fit for our client base. His clinical and medical expertise, as well as his industry experience in the Contract Research Organization, pharmaceutical, biotechnology, and medical device sectors will allow him to make an immediate and positive impact on behalf of our clients. Ira is passionate about clinical research and his passion will certainly be reflected in the service he provides. We look forward to his contributions.”

Dr. Davis joins a highly experienced leadership team which currently consists of Jim Westerkamp, William Irish, PhD, MSc (Chief Scientific Advisor), Peter Mallow, PhD (Health Economics Advisor), and Kenneth Canter (Clinical Development Advisor).

“I believe the ability of Cliniceval Solutions to provide an efficient, comprehensive, and reliable site feasibility analysis will provide a valuable service for the clinical development community, including the patients, who are ultimately going to benefit by a streamlined and timely clinical trial execution,” said Dr. Davis. “This process and ultimate product aligns with our corporate mission of ‘Connecting clinical trial stakeholders to expedite the development of novel therapies to patients in need’.  I look forward to the opportunity to work with the Cliniceval Solutions team and colleagues in the global medical and clinical community.”